Cancer feature: cnaPANCAN177

ADAMTS12 AGXT2 AMACR ANXA2R BRIX1 C1QTNF3 C5orf22 C5orf28 C5orf34 C5orf42 C5orf51 C6 C7 C9 CAPSL CARD6 CCDC152 CCL28 CDH6 DAB2 DNAJC21 DROSHA EGFLAM FBXO4 FGF10 FYB GDNF GHR GOLPH3 HCN1 HMGCS1 IL7R LIFR LMBRD2 MROH2B MRPS30 MTMR12 NADK2 NIM1K NIPBL NNT NPR3 NUP155 OSMR OXCT1 PAIP1 PDZD2 PLCXD3 PRKAA1 PRLR PTGER4 RAD1 RAI14 RANBP3L RICTOR RP11-1084J3.4 RPL37 RXFP3 SEPP1 SKP2 SLC1A3 SLC45A2 SPEF2 SUB1 TARS TTC23L TTC33 UGT3A1 UGT3A2 WDR70 ZFR ZNF131

Known Driver Genes: IL7R

Copy number alternation: gain

Nilotinib

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).

Genomics of Drug Sensitivity in Cancer